Select the drug indication to add to your list


CHF and arrhythmias
Only 4 drugs may be compared at once

Generic Name and Formulations:

Isosorbide dinitrate 20mg, hydralazine HCl 37.5mg; scored tabs.

Select therapeutic use:

Indications for BIDIL:

Heart failure (HF) in black patients, as adjunct to standard treatment, to improve survival, prolong time to hospitalization for HF, and improve patient-reported functional status.

Limitations Of use:

Not established in NYHA Class IV HF.


Initially 1 tab 3 times daily, may reduce to ½ tab 3 times daily if not tolerated; titrate as tolerated after 3–5 days. Max 2 tabs 3 times daily.


Not established.


Allergy to organic nitrates. Concomitant PDE5 inhibitors (eg, avanafil, sildenafil, tadalafil, vardenafil), or riociguat.


Correct volume/salt depletion prior to initiation. Hypotension. Hypertrophic cardiomyopathy. Discontinue if syncope occurs. Give pyridoxine if peripheral neuritis occurs. Hepatic impairment. Elderly. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Vasodilators (nitrate + direct-acting).


See Contraindications. Severe hypotension with PDE5 inhibitors or riociguat.

Adverse Reactions:

Headache (usually transient), dizziness, asthenia, nausea, vomiting, hypotension, sinusitis, tachycardia, paresthesia, amblyopia; SLE.

How Supplied:


BIDIL 20mg/37.5mg tablets (Qty:90)

appx. price $308.00